Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
REATA PHARMACEUTICALS INC | SVP, Chief Medical Officer | Class A common stock | 39.5K | $6.79M | $172.03 | May 16, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RETA | REATA PHARMACEUTICALS INC | May 15, 2023 | 2 | -$53.2K | 4 | May 17, 2023 | SVP, Chief Medical Officer |
RETA | REATA PHARMACEUTICALS INC | Mar 7, 2023 | 1 | -$331K | 4 | Mar 8, 2023 | SVP, Chief Medical Officer |
RETA | REATA PHARMACEUTICALS INC | Mar 2, 2023 | 6 | -$1.68M | 4 | Mar 6, 2023 | SVP, Chief Medical Officer |
RETA | REATA PHARMACEUTICALS INC | Jan 3, 2023 | 2 | $0 | 4 | Jan 4, 2023 | SVP, Chief Medical Officer |
RETA | REATA PHARMACEUTICALS INC | Feb 7, 2022 | 0 | $0 | 3 | Feb 7, 2022 | SVP, Chief Medical Officer |